Firms pave way for drugs 'over counter'
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.TWO of Britain's biggest drug companies have taken a step towards making some popular treatments available without prescription to treat minor illnesses.
Glaxo and Wellcome are linking up with the Warner-Lambert group, based in the United States, to create what will be the largest pharmaceutical company in the world dealing in non-prescription or 'over-the- counter' (OTC) medicines.
It hopes to be able to sell non-prescription versions of Zantac (used to treat ulcers), the world's top-selling prescription drug, and Zovirax (an anti-viral agent), the eighth-largest, in addition to a range of established analgesic, decongestant and other OTC medicines.
Regulatory approval is necessary and OTC versions could only be sold for minor problems.
Drug shares boost, page 29
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments